
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
Hector Bonilla, Michael J. Peluso, Kathleen E. Rodgers, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 60
Hector Bonilla, Michael J. Peluso, Kathleen E. Rodgers, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 60
Showing 1-25 of 60 citing articles:
Long COVID: a clinical update
Trisha Greenhalgh, Manoj Sivan, Alice Perlowski, et al.
The Lancet (2024) Vol. 404, Iss. 10453, pp. 707-724
Closed Access | Times Cited: 78
Trisha Greenhalgh, Manoj Sivan, Alice Perlowski, et al.
The Lancet (2024) Vol. 404, Iss. 10453, pp. 707-724
Closed Access | Times Cited: 78
Post-COVID cognitive dysfunction: current status and research recommendations for high risk population
Meina Quan, Xuechu Wang, Min Gong, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 38, pp. 100836-100836
Open Access | Times Cited: 64
Meina Quan, Xuechu Wang, Min Gong, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 38, pp. 100836-100836
Open Access | Times Cited: 64
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
Felicity Liew, Claudia Efstathiou, Sara Fontanella, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 607-621
Open Access | Times Cited: 41
Felicity Liew, Claudia Efstathiou, Sara Fontanella, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 607-621
Open Access | Times Cited: 41
Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection
Linda N. Geng, Hector Bonilla, Haley Hedlin, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 9, pp. 1024-1024
Open Access | Times Cited: 35
Linda N. Geng, Hector Bonilla, Haley Hedlin, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 9, pp. 1024-1024
Open Access | Times Cited: 35
Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID
Kirsten Baillie, Helen Davies, Samuel Keat, et al.
Med (2024) Vol. 5, Iss. 3, pp. 239-253.e5
Open Access | Times Cited: 23
Kirsten Baillie, Helen Davies, Samuel Keat, et al.
Med (2024) Vol. 5, Iss. 3, pp. 239-253.e5
Open Access | Times Cited: 23
Characterizing Long COVID in Children and Adolescents
Rachel S. Gross, Tanayott Thaweethai, Lawrence C. Kleinman, et al.
JAMA (2024) Vol. 332, Iss. 14, pp. 1174-1174
Closed Access | Times Cited: 22
Rachel S. Gross, Tanayott Thaweethai, Lawrence C. Kleinman, et al.
JAMA (2024) Vol. 332, Iss. 14, pp. 1174-1174
Closed Access | Times Cited: 22
Cardiovascular autonomic dysfunction in “Long COVID”: pathophysiology, heart rate variability, and inflammatory markers
Karina Carvalho Marques, Juarez Antônio Simões Quaresma, Luiz Fábio Magno Falcão
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 27
Karina Carvalho Marques, Juarez Antônio Simões Quaresma, Luiz Fábio Magno Falcão
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 27
Cognitive dysfunction after covid-19
Emma Ladds, Julie Darbyshire, Nawar Diar Bakerly, et al.
BMJ (2024), pp. e075387-e075387
Open Access | Times Cited: 14
Emma Ladds, Julie Darbyshire, Nawar Diar Bakerly, et al.
BMJ (2024), pp. e075387-e075387
Open Access | Times Cited: 14
Cardiovascular effects of the post-COVID-19 condition
Erin Goerlich, Tae Hwan Chung, Gloria Hong, et al.
Nature Cardiovascular Research (2024) Vol. 3, Iss. 2, pp. 118-129
Open Access | Times Cited: 11
Erin Goerlich, Tae Hwan Chung, Gloria Hong, et al.
Nature Cardiovascular Research (2024) Vol. 3, Iss. 2, pp. 118-129
Open Access | Times Cited: 11
Molecular cross-talk between long COVID-19 and Alzheimer’s disease
Magdalena Pszczołowska, Kamil Walczak, Weronika Miśków, et al.
GeroScience (2024) Vol. 46, Iss. 3, pp. 2885-2899
Open Access | Times Cited: 7
Magdalena Pszczołowska, Kamil Walczak, Weronika Miśków, et al.
GeroScience (2024) Vol. 46, Iss. 3, pp. 2885-2899
Open Access | Times Cited: 7
Exploring the Pathophysiology of Long COVID: The Central Role of Low-Grade Inflammation and Multisystem Involvement
Evgeni Gusev, Alexey Sarapultsev
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6389-6389
Open Access | Times Cited: 7
Evgeni Gusev, Alexey Sarapultsev
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6389-6389
Open Access | Times Cited: 7
Current landscape of long COVID clinical trials
Manojit Bhattacharya, Srijan Chatterjee, Sanskriti Saxena, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111930-111930
Closed Access | Times Cited: 6
Manojit Bhattacharya, Srijan Chatterjee, Sanskriti Saxena, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111930-111930
Closed Access | Times Cited: 6
Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia
Hiten Naik, Erin Cooke, Travis Boulter, et al.
BMJ Open (2024) Vol. 14, Iss. 5, pp. e085272-e085272
Open Access | Times Cited: 6
Hiten Naik, Erin Cooke, Travis Boulter, et al.
BMJ Open (2024) Vol. 14, Iss. 5, pp. e085272-e085272
Open Access | Times Cited: 6
Baseline Characteristics in the Remote Diet Intervention to REduce long-COVID Symptoms Trial (ReDIRECT)
Laura Haag, Janice Richardson, Caroline Haig, et al.
NIHR Open Research (2024) Vol. 4, pp. 7-7
Open Access | Times Cited: 5
Laura Haag, Janice Richardson, Caroline Haig, et al.
NIHR Open Research (2024) Vol. 4, pp. 7-7
Open Access | Times Cited: 5
Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for primary care
Udo Zifko, Katja Guendling, Raymond C.S. Seet, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Udo Zifko, Katja Guendling, Raymond C.S. Seet, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Potential Beneficial Effects of Naringin and Naringenin on Long COVID—A Review of the Literature
Siqi Liu, Mengli Zhong, Hao Wu, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 332-332
Open Access | Times Cited: 4
Siqi Liu, Mengli Zhong, Hao Wu, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 332-332
Open Access | Times Cited: 4
A practical framework for Long COVID treatment in primary care
W. Michael Brode, Esther Melamed
Life Sciences (2024) Vol. 354, pp. 122977-122977
Open Access | Times Cited: 4
W. Michael Brode, Esther Melamed
Life Sciences (2024) Vol. 354, pp. 122977-122977
Open Access | Times Cited: 4
COVID-19 and immune dysfunction: Consequences and natural remedies for management
Victoria L. Reed, Tram M. Ta, Maryam Khan, et al.
Elsevier eBooks (2025), pp. 235-264
Closed Access
Victoria L. Reed, Tram M. Ta, Maryam Khan, et al.
Elsevier eBooks (2025), pp. 235-264
Closed Access
Спектр клинических проявлений постковидного синдрома и длительность их сохранения
А.З. Кутманова, B. Abdimomunova, С.Т. Жолдошев, et al.
Scientific and practical journal Healthcare of Kyrgyzstan (2025), Iss. 4, pp. 33-40
Closed Access
А.З. Кутманова, B. Abdimomunova, С.Т. Жолдошев, et al.
Scientific and practical journal Healthcare of Kyrgyzstan (2025), Iss. 4, pp. 33-40
Closed Access
Virus-Induced Pathogenic Antibodies: Lessons from Long COVID and Dengue Hemorrhage Fever
Der‐Shan Sun, Te-Sheng Lien, Hsin‐Hou Chang
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1898-1898
Open Access
Der‐Shan Sun, Te-Sheng Lien, Hsin‐Hou Chang
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1898-1898
Open Access
Chronic stress and post-traumatic stress in long COVID: a comparative survey study
Sofia‐Marie Oehlke, Annika Lozar, Andreas Goreis, et al.
Current Psychology (2025)
Open Access
Sofia‐Marie Oehlke, Annika Lozar, Andreas Goreis, et al.
Current Psychology (2025)
Open Access
mTORC1 syndrome (TorS): unifying paradigm for PASC, ME/CFS and PAIS
Jacob Bar‐Tana
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Jacob Bar‐Tana
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Caveolin Scaffolding Domain (CSD) Peptide LTI-2355 Modulates the Phagocytic and Synthetic Activity of Lung-Derived Myeloid Cells in Idiopathic Pulmonary Fibrosis (IPF) and Post-Acute Sequelae of COVID Fibrosis (PASC-F)
Brecht Creyns, BreAnne MacKenzie, Yago Amigo Pinho Jannini de Sá, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 796-796
Open Access
Brecht Creyns, BreAnne MacKenzie, Yago Amigo Pinho Jannini de Sá, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 796-796
Open Access
Challenges and Opportunities for Post-COVID Pulmonary Disease: A Focused Review of Immunomodulation
Steffi Verbeeck-Mendez, Isabella L. Do Orozco, Guadalupe Estela Gavilanez-Chávez, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3850-3850
Open Access
Steffi Verbeeck-Mendez, Isabella L. Do Orozco, Guadalupe Estela Gavilanez-Chávez, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3850-3850
Open Access
Longitudinal Progression of Patients with Long COVID Treated in a Post-COVID Clinic: A Cross-Sectional Survey
Ryan T. Hurt, Siddhant Yadav, Darrell R. Schroeder, et al.
Journal of Primary Care & Community Health (2024) Vol. 15
Open Access | Times Cited: 3
Ryan T. Hurt, Siddhant Yadav, Darrell R. Schroeder, et al.
Journal of Primary Care & Community Health (2024) Vol. 15
Open Access | Times Cited: 3